About Alverix
Alverix is a company based in San Jose (United States) founded in 2007 was acquired by Becton Dickinson in January 2014.. Alverix has raised $7.7 million across 1 funding round from investors including BD, Safeguard Scientifics and New Venture Partners. Alverix operates in a competitive market with competitors including Inflammatix, Visby Medical, MeMed, GenMark Diagnostics and Molbio Diagnostics, among others.
- Headquarter San Jose, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$7.7 M (USD)
in 1 rounds
-
Latest Funding Round
$7.7 M (USD), Series A
Feb 06, 2008
-
Investors
BD
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Becton Dickinson
(Jan 07, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Alverix
Alverix has successfully raised a total of $7.7M through 1 strategic funding round. The most recent funding activity was a Series A round of $7.7 million completed in February 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $7.7M
-
First Round
First Round
(06 Feb 2008)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2008 | Amount | Series A - Alverix | Valuation | New Venture Partners , Safeguard Scientifics |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alverix
Alverix has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include BD, Safeguard Scientifics and New Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed-to-growth investments are made in US and Europe.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in early and growth stage companies
|
Founded Year | Domain | Location | |
|
BD is recognized for providing innovative medical technology solutions.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alverix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Alverix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alverix Comparisons
Competitors of Alverix
Alverix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Visby Medical, MeMed, GenMark Diagnostics and Molbio Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular platforms for infectious disease detection are developed.
|
|
| domain | founded_year | HQ Location |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Alverix
When was Alverix founded?
Alverix was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Where is Alverix located?
Alverix is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Is Alverix a funded company?
Alverix is a funded company, having raised a total of $7.7M across 1 funding round to date. The company's 1st funding round was a Series A of $7.7M, raised on Feb 06, 2008.
What does Alverix do?
Alverix produces instruments and connectivity platforms for diagnostic Point-of-Care (POC) testing. Alverix claims that its systems enable laboratory class quantitative and qualitative assays in a mobile, portable, less expensive format and that this enables extended precision testing beyond high volume sites to physician office labs, retail clinics, emerging markets and the home. Alverix partners with diagnostic and OEM manufacturers who seek to increase current test accuracy, improve the portability of existing tests, or develop new assays for use in physician offices, laboratory outreach locations, retail clinics, and patient homes.Their San Jose Headquarters handles RD, Design Quality Control. Another facility in Penang, Malaysia facility fulfills manufacturing related functions.
Who are the top competitors of Alverix?
Alverix's top competitors include Visby Medical, Inflammatix and MeMed.
Who are Alverix's investors?
Alverix has 3 investors. Key investors include BD, Safeguard Scientifics, and New Venture Partners.